| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/02/2013 | US20130108668 Therapeutic Polymeric Nanoparticles Comprising Epothilone and Methods of Making and Using Same |
| 05/02/2013 | US20130108667 Method, apparatus and system for electroporation |
| 05/02/2013 | US20130108665 Recombinant tumor vaccine and method of producing such vaccine |
| 05/02/2013 | US20130108652 Asthma diagnosis using the neuropilin-1 gene, and method for screening for a therapeutic agent for asthma |
| 05/02/2013 | US20130108646 Optimized degenerative muscle disease diagnostics and treatments |
| 05/02/2013 | US20130108645 Methods for enhancing axonal regeneration |
| 05/02/2013 | US20130108641 Anti-gitr antibodies |
| 05/02/2013 | US20130108610 Inhibition of Microbial Growth by Aconitase Inhibition |
| 05/02/2013 | US20130108605 Method of ameliorating oxidative stress and supplementing the diet |
| 05/02/2013 | US20130108603 Collagen production compound |
| 05/02/2013 | US20130108602 Methods and uses of nur77 and nur77 agonists to modulate macrophages and monocytes, and treat inflammation, inflammatory disease and cardiovascular disease |
| 05/02/2013 | US20130108586 Composition and method of delivery of l-arabinose and select compounds |
| 05/02/2013 | US20130108583 Methods of use for cyclopamine analogs |
| 05/02/2013 | US20130108582 Methods of use of cyclopamine analogs |
| 05/02/2013 | US20130108581 Immunocytokines for Cancer Treatment in Combination with Chemotherapeutic Agents |
| 05/02/2013 | US20130108579 Methods of using small compounds to enhance myeloid derived suppressor cell function for treating autoimmune diseases |
| 05/02/2013 | US20130108576 Stable antiseptic compositions and methods |
| 05/02/2013 | US20130108573 Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease |
| 05/02/2013 | US20130108564 Compounds with a Skin Pigmenting Activity And Pharmaceutical or Cosmetic Compositions Containing Them |
| 05/02/2013 | US20130108563 Compositions comprising at least one aqueous phase and at least one fatty phase which comprises avermectin compounds |
| 05/02/2013 | US20130108558 Formulation comprising nicotine and a cation exchange resin |
| 05/02/2013 | US20130104881 Stabilized Metered Dose Inhaler |
| 05/02/2013 | DE102011117421A1 Pharmaceutical composition useful for treating Lyme disease, comprises mixture of active substances including ceftriaxone and cefotaxime |
| 05/02/2013 | DE102011117128A1 Verbindungen zur Therapie der Influenza Compounds for the treatment of influenza |
| 05/02/2013 | DE102011054972A1 Goldverbindungen mit Alkinyl-Liganden und deren therapeutische Verwendung Gold compounds with alkynyl ligands and their therapeutic use |
| 05/02/2013 | CA2856608A1 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof |
| 05/02/2013 | CA2853826A1 Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m1 |
| 05/02/2013 | CA2853822A1 Biomarkers of response to nae inhibitors |
| 05/02/2013 | CA2853732A1 Nonaqueous compositions for bone hemostasis, and methods for their use and manufacture |
| 05/02/2013 | CA2853729A1 Novel compositions and methods for treating cancer |
| 05/02/2013 | CA2853722A1 Inhibiting g protein coupled receptor 6 kinase polypeptides |
| 05/02/2013 | CA2853715A1 Compounds for the treatment of influenza |
| 05/02/2013 | CA2853701A1 Artemisinin and berberine compositions and methods of making |
| 05/02/2013 | CA2853688A1 Aminoalkyl-substituted n-thienylbenzamide derivative |
| 05/02/2013 | CA2853648A1 Amide derivatives of n-urea substituted amino acids as formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 05/02/2013 | CA2853633A1 Caffeinated compounds and compositions for treatment of amyloid diseases and synucleinopathies |
| 05/02/2013 | CA2853609A1 Inhibition of viral gene expression |
| 05/02/2013 | CA2853520A1 Electrolyte purgatives |
| 05/02/2013 | CA2853501A1 Methyltransferase inhibitors for treating cancer |
| 05/02/2013 | CA2853485A1 Compounds for inflammation and immune-related uses |
| 05/02/2013 | CA2853484A1 Cysteamine in the treatment of fibrotic disease |
| 05/02/2013 | CA2853472A1 Pharmaceutical composition and kit for treating bacterial infections |
| 05/02/2013 | CA2853466A1 Agents, methods, and devices for affecting nerve function |
| 05/02/2013 | CA2853460A1 Method for the formulation of hand sanitizer |
| 05/02/2013 | CA2853455A1 Meglumine salt formulations of 1-(5,6-dichloro-1h-benzo[d]imidazol-2-yl)-1h-pyrazole-4-carboxylic acid |
| 05/02/2013 | CA2853440A1 Kinase inhibitor and method for treatment of related diseases |
| 05/02/2013 | CA2853407A1 Primycin and components thereof for use in the treatment or prevention of infections caused by specific pathogens |
| 05/02/2013 | CA2853390A1 Anticancer pyridopyrazines via the inhibition of fgfr kinases |
| 05/02/2013 | CA2853373A1 Antisense modulation of gccr expression |
| 05/02/2013 | CA2853367A1 New compounds |
| 05/02/2013 | CA2853366A1 Quinolines as fgfr kinase modulators |
| 05/02/2013 | CA2853285A1 Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases |
| 05/02/2013 | CA2853279A1 Cyclohexylamines |
| 05/02/2013 | CA2853251A1 Implantable rasagiline compositions and methods of treatment thereof |
| 05/02/2013 | CA2853249A1 Implantable tizanidine compositions and methods of treatment thereof |
| 05/02/2013 | CA2853231A1 Pyridazine derivatives useful in therapy |
| 05/02/2013 | CA2853227A1 Azole derivative |
| 05/02/2013 | CA2853221A1 Bicyclic compound |
| 05/02/2013 | CA2853187A1 A method of treating mucus hypersecretion |
| 05/02/2013 | CA2853117A1 Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof |
| 05/02/2013 | CA2853100A1 Compositions and methods for treatment of proteinopathies |
| 05/02/2013 | CA2853097A1 Novel trpv3 modulators |
| 05/02/2013 | CA2853095A1 Method of treating gastrointestinal stromal tumors |
| 05/02/2013 | CA2853062A1 Pyridine- sulfoximines as tyrosine kinase inhibitors |
| 05/02/2013 | CA2852957A1 Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease |
| 05/02/2013 | CA2852808A1 New therapy for transthyretin-associated amyloidosis |
| 05/02/2013 | CA2852796A1 Benzoxazolinone compounds with selective activity in voltage-gated sodium channels |
| 05/02/2013 | CA2852743A1 Fused bicyclic oxazolidinone cetp inhibitor |
| 05/02/2013 | CA2852652A1 Synthesis of triazolopyrimidine compounds |
| 05/02/2013 | CA2852627A1 Heterocyclic derivative having pgd2 receptor antagonist activity |
| 05/02/2013 | CA2852404A1 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases |
| 05/02/2013 | CA2852114A1 Sweet tart energy tablet |
| 05/02/2013 | CA2851930A1 Novel pyrazine derivatives |
| 05/02/2013 | CA2851690A1 Treatment protocol of diabetes type 2 |
| 05/02/2013 | CA2851476A1 Lipid conjugates in the treatment of chronic rhinosinusitis |
| 05/02/2013 | CA2851331A1 Improved cross-linking composition delivered by iontophoresis, useful for the treatment of keratoconus |
| 05/02/2013 | CA2851062A1 1-cycloalkyl- or 1-heterocyclyl-hydroxyimino-3-phenyl-propanes |
| 05/02/2013 | CA2850925A1 Chemical compounds |
| 05/02/2013 | CA2850908A1 Aqueous antimicrobial composition containing coniferous resin acids |
| 05/02/2013 | CA2850034A1 Therapeutic combinations and methods of treating melanoma |
| 05/02/2013 | CA2849977A1 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies |
| 05/02/2013 | CA2849114A1 Sialic acid analogs |
| 05/02/2013 | CA2848263A1 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases |
| 05/02/2013 | CA2846394A1 Treatment of rhinitis |
| 05/02/2013 | CA2846066A1 Hydroxamate derivatives for hdac inhibitor, and the pharmaceutical composition comprising thereof |
| 05/02/2013 | CA2839390A1 Quinone based nitric oxide donating compounds |
| 05/01/2013 | EP2586869A1 Procedure for the obtainment of fatty acids of pharmacological and nutritional interest |
| 05/01/2013 | EP2586864A1 Upregulating of miR-15b for preventing cellular senescence and tissue aging |
| 05/01/2013 | EP2586796A1 Compositions and methods for use for antibodies against sclerostin |
| 05/01/2013 | EP2586794A2 Manufacture, Compositions and Uses of Coagulationfactor VIIA Modulator |
| 05/01/2013 | EP2586786A1 Sulphated amino sugars with anti-inflammatory properties |
| 05/01/2013 | EP2586785A1 Phosphoric acid ester compound of hydroxy acid substituted phenyl ester, synthesis method and medical use thereof |
| 05/01/2013 | EP2586782A1 Crystalline salts of sitagliptin |
| 05/01/2013 | EP2586781A1 Novel condensed pyridine or condensed pyrimidine derivative, and medicinal agent comprising same |
| 05/01/2013 | EP2586780A1 2-aryl imidazo[1,2-a]pyridine-3-acetamide derivatives, preparation methods and use thereof |
| 05/01/2013 | EP2586778A2 Pyridazinone derivatives useful as glucan synthase inhibitors |
| 05/01/2013 | EP2586776A1 Soft cationic mitochondrial uncouplers |
| 05/01/2013 | EP2586774A1 Method for preparation of ranolazine |
| 05/01/2013 | EP2586773A1 Synthesis of Triazolopyrimidine Compounds |
| 05/01/2013 | EP2586772A1 Isoquinoline derivative |